Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer.

Zahran, Asmaa M; Rayan, Amal; Zahran, Zeinab Albadry M; Mohamed, Wael M Y; Mohamed, Dalia O; Abdel-Rahim, Mona H; El-Badawy, Omnia

Zahran, Asmaa M; Rayan, Amal; Zahran, Zeinab Albadry M; Mohamed, Wael M Y; Mohamed, Dalia O; Abdel-Rahim, Mona H; El-Badawy, Omnia.

Afiliação

Zahran AM; Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Rayan A; Clinical Oncology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Zahran ZAM; Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Mohamed WMY; Oncology Department, Faculty of Medicine, Port Said University, Port Said, Egypt.
Mohamed DO; Consultant Medical Oncologist Locum, Swansea University Hospital, Swansea, United Kingdom.
Abdel-Rahim MH; Department of Radiation Oncology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
El-Badawy O; Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.

PLoS One ; 17(1): e0262650, 2022.

Article em En | MEDLINE | ID: mdl-35051220

Assuntos

Antígenos CD/metabolismo; Apirase/metabolismo; Linfócitos do Interstício Tumoral/metabolismo; Linfócitos/metabolismo; Receptor de Morte Celular Programada 1/metabolismo; Neoplasias de Mama Triplo Negativas/metabolismo; Adulto; Idoso; Biomarcadores Tumorais/metabolismo; Progressão da Doença; Feminino; Humanos; Linfócitos/patologia; Linfócitos do Interstício Tumoral/patologia; Pessoa de Meia-Idade; Prognóstico; Taxa de Sobrevida; Neoplasias de Mama Triplo Negativas/mortalidade; Neoplasias de Mama Triplo Negativas/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Apirase / Linfócitos / Antígenos CD / Linfócitos do Interstício Tumoral / Receptor de Morte Celular Programada 1 / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: PLoS One Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google